Owners, management and financials
CVR: 27406793
Secondary names: FERTILITECH A/S, UNISENSE FERTILITECH A/S
DKK 228,406,323
Gross profit
Net result: DKK 110,485,853
Vitrolife AB (100%)
CVR · view owners
Dag Erik Rickard Ericsson
Board: Sten Jakob Hedén (chair) and 2 members
CVR · view management
Active
Founded 20 October 2003
CVR · view overview
79 employees
CVR · 2018
Director role ended: Claus Bisgaard
CVR · 24/10/2025
View the full event history
VITROLIFE A/S is a Danish company of the type Aktieselskab based in Viby J, founded in 2003. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Dag Erik Rickard Ericsson. The board consists of Sten Jakob Hedén (chair), Dag Erik Rickard Ericsson and Tom Faes. The company is owned by Vitrolife AB. The company has 79 employees (2018). In 2025, the company reported a gross profit of DKK 228,406,323 and a net result of DKK 110,485,853 compared with DKK 130,285,262 the year before. Equity in the 2025 report amounted to DKK 327,839,900.
Source: annual report 2025, Danish Business Authority
VITROLIFE A/S demonstrates a solid financial health with consistent profitability over the past five years, highlighted by a gross profit of 228.4 million DKK and a profit of 110.5 million DKK in 2025. The company has shown a stable trend in gross profit, with figures ranging from 194.2 million DKK in 2021 to 249.7 million DKK in 2024, indicating effective cost management and operational efficiency. Equity has steadily increased from 247.5 million DKK in 2021 to 327.8 million DKK in 2025, reflecting a strong balance sheet and financial stability. However, the absence of revenue data raises concerns about transparency and could limit insights into overall market performance. Positioned within the medical and dental instruments industry, VITROLIFE A/S appears to be a competitive player with a robust profit margin and growing equity base.
AI-generated summary · Generated 16/08/2026
Selskabets formål er er at udvikle, demonstrere og kommercialisere udstyr til optimering af fertilitetsbehandling samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 228.4 mio. | 110.5 mio. | 387.2 mio. | 327.8 mio. | 116 | |
| 202401/01/2024 – 31/12/2024 | 249.7 mio. | 130.3 mio. | 377.8 mio. | 316.7 mio. | 108 | |
| 202301/01/2023 – 31/12/2023 | 216.8 mio. | 103.2 mio. | 286.2 mio. | 239.4 mio. | 100 | |
| 202201/01/2022 – 31/12/2022 | 219.3 mio. | 107.8 mio. | 295.9 mio. | 255.8 mio. | 90 | |
| 202101/01/2021 – 31/12/2021 | 194.2 mio. | 96.5 mio. | 323.2 mio. | 247.5 mio. | 86 | |
| 202001/01/2020 – 31/12/2020 | 130.4 mio. | 57.3 mio. | 266.7 mio. | 210.6 mio. | 82 | |
| 201901/01/2019 – 31/12/2019 | 183 mio. | 94.3 mio. | 209.7 mio. | 153.2 mio. | 81 | |
| 201801/01/2018 – 31/12/2018 | 145.2 mio. | 68.3 mio. | 133.8 mio. | 58.9 mio. | 77 | |
| 201701/01/2017 – 31/12/2017 | 135.1 mio. | 62.5 mio. | 187.7 mio. | 160.6 mio. | 95 | |
| 201601/01/2016 – 31/12/2016 | 65.3 mio. | 11.6 mio. | 122.8 mio. | 98 mio. | 64 | |
| 201501/01/2015 – 31/12/2015 | 56.5 mio. | 42.7 mio. | 133.7 mio. | 86.5 mio. | 64 | |
| 201401/01/2014 – 31/12/2014 | 11.9 mio. | -58 mio. | 113.7 mio. | 43.8 mio. | 77 | |
| 201301/01/2013 – 31/12/2013 | 22.5 mio. | -34.1 mio. | 139.9 mio. | 49.8 mio. | 72 | |
| 201201/01/2012 – 31/12/2012 | 24 mio. | -14.1 mio. | 115.8 mio. | 78.1 mio. | - |
Compared to 309 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of VITROLIFE A/S is 27406793.
VITROLIFE A/S is owned by Vitrolife AB.
The management of VITROLIFE A/S consists of Dag Erik Rickard Ericsson.
The board of VITROLIFE A/S consists of Sten Jakob Hedén, Dag Erik Rickard Ericsson and Tom Faes, with Sten Jakob Hedén as chair.
In 2025, VITROLIFE A/S reported a gross profit of DKK 228,406,323.
VITROLIFE A/S had 79 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
VITROLIFE A/S has published its annual report for 2025. Gross profit came to DKK 228,406,323, and the net result was DKK 110,485,853.
As of October 24, 2025, Dag Erik Rickard Ericsson has joined the board of directors of VITROLIFE A/S.
As of October 24, 2025, Sten Jakob Hedén has joined the board of directors of VITROLIFE A/S.
As of October 24, 2025, Claus Bisgaard has left the board of directors of VITROLIFE A/S.
As of October 24, 2025, Dag Erik Rickard Ericsson is registered as adm. dir. of VITROLIFE A/S.
As of October 24, 2025, Claus Bisgaard has stepped down as adm. dir. of VITROLIFE A/S.
As of October 23, 2025, Dag Erik Rickard Ericsson has left the board of directors of VITROLIFE A/S.
As of June 4, 2025, Tom Faes has joined the board of directors of VITROLIFE A/S.
As of June 4, 2025, Bo Lars Risberg has left the board of directors of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2024. Gross profit came to DKK 249,706,731, and the net result was DKK 130,285,262.
As of February 21, 2025, Dag Erik Rickard Ericsson has joined the board of directors of VITROLIFE A/S.
As of February 21, 2025, Tony Patrik Tolf has left the board of directors of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2023. Gross profit came to DKK 216,829,286, and the net result was DKK 103,152,563.
VITROLIFE A/S has published its annual report for 2022. Gross profit came to DKK 219,325,000, and the net result was DKK 107,758,000.
As of March 31, 2023, Tony Patrik Tolf has joined the board of directors of VITROLIFE A/S.
As of March 31, 2023, Hans Thomas Axelsson has left the board of directors of VITROLIFE A/S.
As of March 30, 2023, Tony Patrik Tolf has left the board of directors of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2021. Gross profit came to DKK 194,178,750, and the net result was DKK 96,519,013.
As of January 10, 2022, Tony Patrik Tolf has joined the board of directors of VITROLIFE A/S.
As of January 10, 2022, Bo Lars Risberg has joined the board of directors of VITROLIFE A/S.
As of January 10, 2022, Erik Mikael Engblom has left the board of directors of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2020. Gross profit came to DKK 130,351,767, and the net result was DKK 57,316,046.
VITROLIFE A/S has published its annual report for 2019. Gross profit came to DKK 183,030,800, and the net result was DKK 94,297,730.
VITROLIFE A/S has published its annual report for 2018. Gross profit came to DKK 145,249,655, and the net result was DKK 68,302,685.
As of May 23, 2019, Claus Bisgaard has joined the board of directors of VITROLIFE A/S.
As of May 23, 2019, Steffen Broe Nielsen has left the board of directors of VITROLIFE A/S.
As of May 23, 2019, Claus Bisgaard is registered as adm. dir. of VITROLIFE A/S.
As of May 23, 2019, Steffen Broe Nielsen has stepped down as adm. dir. of VITROLIFE A/S.
As of May 22, 2019, Claus Bisgaard has stepped down as director of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2017. Gross profit came to DKK 135,053,555, and the net result was DKK 62,516,615.
As of December 1, 2017, Claus Bisgaard is registered as director of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2016. Gross profit came to DKK 65,345,949, and the net result was DKK 11,582,397.
VITROLIFE A/S has published its annual report for 2015. Gross profit came to DKK 56,487,022, and the net result was DKK 42,716,230.
As of May 31, 2016, Steffen Broe Nielsen has joined the board of directors of VITROLIFE A/S.
As of May 31, 2016, Hans Thomas Axelsson has joined the board of directors of VITROLIFE A/S.
As of May 31, 2016, Per Stefan Harry Pettersson has left the board of directors of VITROLIFE A/S.
As of May 30, 2016, Hans Thomas Axelsson has left the board of directors of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2014. Gross profit came to DKK 11,865,734, and the net result was DKK -57,971,985.
As of February 5, 2015, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of VITROLIFE A/S.
As of February 5, 2015, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of VITROLIFE A/S.
As of February 5, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of VITROLIFE A/S.
As of December 4, 2014, Steffen Broe Nielsen is registered as adm. dir. of VITROLIFE A/S.
As of December 4, 2014, Michael Reeslev has stepped down as adm. dir. of VITROLIFE A/S.
As of November 26, 2014, Hans Thomas Axelsson has joined the board of directors of VITROLIFE A/S.
As of November 26, 2014, Per Stefan Harry Pettersson has joined the board of directors of VITROLIFE A/S.
As of November 26, 2014, Erik Mikael Engblom has joined the board of directors of VITROLIFE A/S.
As of November 26, 2014, Søren Nielsen has left the board of directors of VITROLIFE A/S.
As of November 26, 2014, Christian Grøndahl has left the board of directors of VITROLIFE A/S.
As of November 26, 2014, Claus Jørgensen has left the board of directors of VITROLIFE A/S.
As of November 26, 2014, Lars Rabe Tønnesen has left the board of directors of VITROLIFE A/S.
As of November 26, 2014, is registered as an owner of VITROLIFE A/S with an ownership share of 100%.
VITROLIFE A/S has published its annual report for 2013. Gross profit came to DKK 22,464,717, and the net result was DKK -34,101,319.
As of June 14, 2013, Michael Reeslev is registered as adm. dir. of VITROLIFE A/S.
As of June 14, 2013, Jens Kristian Ellekilde Gundersen has stepped down as director of VITROLIFE A/S.
VITROLIFE A/S has published its annual report for 2012. Gross profit came to DKK 23,954,175, and the net result was DKK -14,069,985.
As of May 30, 2013, Christian Grøndahl has joined the board of directors of VITROLIFE A/S.
As of May 30, 2013, Tom Henning Riisom has left the board of directors of VITROLIFE A/S.
As of March 1, 2013, Claus Jørgensen has joined the board of directors of VITROLIFE A/S.
As of November 23, 2012, Søren Nielsen has joined the board of directors of VITROLIFE A/S.
As of November 23, 2012, Kirsten Marie Jakobsen has left the board of directors of VITROLIFE A/S.
As of November 23, 2012, Manuel de la Llave has left the board of directors of VITROLIFE A/S.
As of May 23, 2012, Lars Rabe Tønnesen has joined the board of directors of VITROLIFE A/S.
As of May 23, 2012, Hans Jørgen Angaard Madsen has left the board of directors of VITROLIFE A/S.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of VITROLIFE A/S.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of VITROLIFE A/S.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of VITROLIFE A/S.
As of May 30, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of VITROLIFE A/S.
As of May 30, 2011, SLP NR. 10.814 A/S has stepped down as auditor of VITROLIFE A/S.
As of May 30, 2011, Hans Jørgen Angaard Madsen has joined the board of directors of VITROLIFE A/S.
As of May 30, 2011, Kirsten Marie Jakobsen has joined the board of directors of VITROLIFE A/S.
As of May 30, 2011, Manuel de la Llave has joined the board of directors of VITROLIFE A/S.
As of May 30, 2011, Jens Kristian Ellekilde Gundersen has left the board of directors of VITROLIFE A/S.
As of May 30, 2011, Sylvie Elisabeth Bove has left the board of directors of VITROLIFE A/S.
As of December 2, 2010, Jens Kristian Ellekilde Gundersen has joined the board of directors of VITROLIFE A/S.
As of December 2, 2010, Peter Mørch Eriksen has left the board of directors of VITROLIFE A/S.
As of April 26, 2010, Peter Mørch Eriksen has joined the board of directors of VITROLIFE A/S.
As of April 26, 2010, Tom Henning Riisom has joined the board of directors of VITROLIFE A/S.
As of July 9, 2009, Carl Erik Skovgaard has left the board of directors of VITROLIFE A/S.
As of May 18, 2009, Jens Borum has left the board of directors of VITROLIFE A/S.
As of January 23, 2009, Jens Borum has joined the board of directors of VITROLIFE A/S.
As of February 9, 2007, Sylvie Elisabeth Bove has joined the board of directors of VITROLIFE A/S.
As of February 9, 2007, Per Christian Gernow has left the board of directors of VITROLIFE A/S.
As of September 16, 2005, Carl Erik Skovgaard has joined the board of directors of VITROLIFE A/S.
As of September 16, 2005, Per Christian Gernow has joined the board of directors of VITROLIFE A/S.
As of October 20, 2003, SLP NR. 10.814 A/S has been appointed auditor of VITROLIFE A/S.
As of October 20, 2003, Jens Kristian Ellekilde Gundersen is registered as director of VITROLIFE A/S.
VITROLIFE A/S was founded on October 20, 2003.
Companies in the same industry and area
CVR 34322988
CVR 33268963
CVR 27628591
CVR 11121292
CVR 66505928
